Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances

Pathology Research and Practice

Volumn 208, Issue 7, 2012, Pages 392-397

  Shu, Guo shun ^a   Yang, Zhu lin ^a   Liu, Dong cai ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Dicer; Drosha; Gallbladder cancer; Immunohistochemsitry

Indexed keywords

DICER; DROSHA ENZYME; ENZYME; MICRORNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; GALLBLADDER CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; RADICAL RESECTION;

ADENOCARCINOMA; ADULT; AGED; BIOLOGICAL MARKERS; CHINA; CHOLECYSTECTOMY; EPITHELIUM; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RIBONUCLEASE III; SURVIVAL RATE;

EID: 84863831926     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.05.001     Document Type: Article

References (28)

1. Randi G., Franceschi S., La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int. J. Cancer 2006, 118:1591-1602.
2. Jayaraman S., Jarnagin W.R. Management of gallbladder cancer. Gastroenterol. Clin. North Am. 2010, 39:331-342.
3. Reid K.M., Ramos-De la Medina A., Donohue J.H. Diagnosis and surgical management of gallbladder cancer: a review. J. Gastrointest. Surg. 2007, 11:671-681.
4. Srivastava K., Srivastava A., Sharma K.L., Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat. Res. 2011, 728:67-79.
5. Yang Z., Yang Z., Xiong L., Huang S., Liu J., Yang L., Miao X. Expression of VHL and HIF-1α and their clinicopathologic significance in benign and malignant lesions of the gallbladder. Appl. Immunohistochem. Mol. Morphol. 2011, 19:534-539.
6. Pignochino Y., Sarotto I., Peraldo-Neia C., Penachioni J.Y., Cavalloni G., Migliardi G., Casorzo L., Chiorino G., Risio M., Bardelli A., Aglietta M., Leone F. Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. BMC Cancer 2010, 10:631.
7. Liu D.C., Yang Z.L. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. Diagn. Cytopathol. 2011, 10.1002/dc.21821.
8. Wang J., Zhang M., Zhang L., Cai H., Zhou S., Zhang J., Wang Y. Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. J. Surg. Res. 2010, 164:e99-e105.
9. Liu B., Zhang Y., Liao M., Deng Z., Gong L., Jiang J., Lynn L., Wu K., Miao X. Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma. Pathol. Oncol. Res. 2011, 17:45-50.
10. Liu D.C., Yang Z.L., Jiang S. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Pathol. Oncol. Res. 2011, 17:859-866.
11. Kim H., Song J.Y., Cho J.Y., Yoon Y.S., Han H.S., Lee H.S., Ryu H.S., Choe G. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis. J. Clin. Pathol. 2010, 63:1048-1053.
12. Liu D.C., Yang Z.L. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathol. Res. Pract. 2011, 207:472-478.
13. Bar N., Dikstein R. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One 2010, 5:e10859.
14. Dedes K.J., Natrajan R., Lambros M.B., Geyer F.C., Lopez-Garcia M.A., Savage K., Jones R.L., Reis-Filho J.S. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur. J. Cancer 2011, 47:138-150.
15. Merritt W.M. Dicer, Drosha, and outcomes in patients with ovarian cancer. New Engl. J. Med. 2010, 363:1877.
16. Karube Y., Tanaka H., Osada H., Tomida S., Tatematsu Y., Yanagisawa K., Yatabe Y., Takamizawa J., Miyoshi S., Mitsudomi T., Takahashi T. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005, 96:111-115.
17. Grelier G., Voirin N., Ay A.S. Prognositic value of Dicer expression in human breast cancers and associated with the mesenchymal phenotype. Br. J. Cancer 2009, 101:673-683.
18. Lin R., Lin Y., Chen J.J. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res. 2010, 70:7841-7850.
19. Faber C., Horst D., Hlubek F., Kirchner T. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur. J. Cancer 2011, 47:1414-1419.
20. Papachristou D.J., Korpetinou A., Giannopoulou E., Antonacopoulou A.G., Papadaki H., Grivas P., Scopa C.D., Kalofonos H.P. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Wirch. Arch. 2011, 459:431-440.
21. Sand M., Gambichler T., Skrygan M., Sand D., Scola N., Altmeyer P., Bechara F.G. Expression levels of the microRNA processing enzymes Drosha and Dicer in epithelial skin cancer. Cancer Invest. 2010, 28:649-653.
22. Chiosea S.L., Barnes E.L., Lai S.Y., Egloff A.M., Sargent R.L., Hunt J.L., Seethala R.R. Mucoepidemoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Airvichows Arch. 2008, 452:629-635.
23. Davis-Dusenbery B.N., Hata A. Mechanisms of control of microRNA biogenesis. J. Biochem. 2010, 148:381-392.
24. Ting A.H., Suzuki H., Cope L., Schuebel K.E., Lee B.H., Toyota M., Imai K., Shinomura Y., Tokino T., Baylin S.B. A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells. Cancer Res. 2008, 68:2570-2575.
25. Kanellopoulou C., Muljo S.A., Kung A.L., Ganesan S., Drapkin R., Jenuwein T., Livingston D.M., Rajewsky K. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 2005, 19:489-501.
26. Wiesen J.L., Tomasi T.B. Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 2009, 46:1222-1228.
27. Tokumaru S., Suzuki M., Yamada H., Nagino M., Takahashi T. Let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008, 29:2073-2077.
28. Haase A., Jaskiewicz L., Zhang H., Lainé D., Sack R., Gatignol A., Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005, 6:961-967.